Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Licenses Lexicon Technology

NEW YORK, June 7-Lexicon Genetics has granted a license to its isogenic DNA technology to Millennium Pharmaceuticals, the company said yesterday.


The license, which is nonexclusive, will allow Millennium to use the technology in drug discovery and target validation.


Financial details were not disclosed.


Lexicon, based in The Woodlands, Tx., has developed a range of techniques to improve gene knockout technology.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.